Brief: Aptinyx Recommences Patient Recruitment In Phase 2 Study Of NYX-2925

Aptinyx

28/09/2020 13:39

Sept 28 (Reuters) - Aptinyx Inc  APTX.O :
    * APTINYX RECOMMENCES PATIENT RECRUITMENT IN PHASE 2 STUDY
OF
NYX-2925 IN PATIENTS WITH FIBROMYALGIA
    * APTINYX INC - ON TRACK TO RECOMMENCE SEPARATE PHASE 2
STUDY OF
NYX-2925 IN PAINFUL DPN IN 4Q 2020
    * APTINYX INC - EXPECT TO REPORT DATA FROM STUDY IN FIRST
HALF OF
2022

Source text for Eikon:  ID:nBw9lnbqfa 
Further company coverage:  APTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))